八十岁以上非小细胞肺癌患者接受亚肺叶切除的前瞻性多中心研究
这项前瞻性多中心注册研究纳入419例年龄≥80岁、肿瘤2-4cm的非小细胞肺癌患者,比较亚肺叶切除与肺叶切除的生存结局。中位随访50.9个月,亚肺叶切除组5年总生存率54.7% vs 肺叶切除组66.8%(P=0.09),多因素分析显示手术方式非独立预后因素(HR 0.8,P=0.16)。在可耐受肺叶切除的患者中,两种术式5年总生存率相当(67.5% vs 71.5%,P=0.79)。
要点
- 419例≥80岁、2-4cm早期NSCLC患者,亚肺叶切除与肺叶切除5年OS无显著差异(54.7% vs 66.8%,P=0.09)。
- 可耐受肺叶切除者中,亚肺叶切除与肺叶切除5年OS相当(67.5% vs 71.5%,P=0.79)。
- 亚肺叶切除局部复发11/97(11%),肺叶切除23/322(7%)。
核心结论
- 对于可耐受肺叶切除的、肿瘤2-4cm的周围型早期NSCLC且年龄≥80岁的选定患者,保证手术切缘的亚肺叶切除与肺叶切除的总生存可能相当。
研究设计与样本
- 前瞻性多中心注册研究,纳入82家机构中年龄≥80岁可手术肺癌患者892例,分析其中419例肿瘤2-4cm的NSCLC患者,中位随访50.9个月,入组时间为2015年4月至2016年12月。
主要发现
- 全队列中亚肺叶切除与肺叶切除的5年总生存率分别为54.7%(95%CI 43.2%-93.0%)与66.8%(95%CI 60.8%-72.1%),差异无统计学显著(P=0.09)。
- 多因素Cox回归分析显示手术方式不是总生存的独立预后因素(HR 0.8,95%CI 0.5-1.1,P=0.16)。
- 在192例可耐受肺叶切除但接受亚肺叶切除或肺叶切除的患者中,5年总生存率分别为67.5%(95%CI 48.8%-80.6%)与71.5%(95%CI 62.9%-78.4%),差异无统计学显著(P=0.79)。
- 亚肺叶切除组局部复发11/97(11%),肺叶切除组局部复发23/322(7%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Segmentectomy is a good surgical option for peripheral, early, non-small cell lung cancer (NSCLC) ≤2 cm. However, the role of sublobar resection including wedge resection and segmentectomy remains unclear for octogenarians with >2-cm but ≤4-cm early-stage NSCLC, for which lobectomy is a standard treatment. METHODS: By use of a prospective registry, 892 patients aged ≥80 years with operable lung cancer were enrolled at 82 institutions. Of these, we analyzed the clinicopathologic findings and surgical outcomes of 419 patients with NSCLC tumors of 2 to 4 cm during a median follow-up of 50.9 months between April 2015 and December 2016. RESULTS: Five-year overall survival (OS) was slightly but not significantly worse after sublobar resection than after lobectomy in the entire cohort (54.7% [95% CI, 43.2%-93.0%] vs 66.8% [95% CI, 60.8%-72.1%]; P = .09). Multivariable Cox regression analysis of OS revealed that these surgical procedures were not independent prognostic predictors (hazard ratio, 0.8 [0.5-1.1]; P = .16). The 5-year OS was comparable between 192 patients who could tolerate lobectomy but were treated by sublobar resection or lobectomy (67.5% [95% CI, 48.8%-80.6%] vs 71.5% [95% CI, 62.9%-78.4%]; P = .79). Recurrence after sublobar resection and lobectomy was locoregional in 11 (11%) of 97 and in 23 (7%) of 322 patients, respectively. CONCLUSIONS: OS might be equivalent between sublobar resection with a secure surgical margin and lobectomy for selected patients aged ≥80 years with peripheral early-stage NSCLC tumors of 2 to 4 cm who can tolerate lobectomy.
引用
- Mimae T, Saji H, Nakamura H, et al. Sublobar Resection for Non-Small Cell Lung Cancer in Octogenarians: A Prospective, Multicenter Study. Ann Thorac Surg. 2023. PMID: 37004802. doi:10.1016/j.athoracsur.2023.02.061
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。